A Canadian startup called Xanadu has built a photon-based quantum computer it says should easily scale up. What will really matter in the long run? That’s the question we tackle each year as we ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

Stephens reiterated their equal weight rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report ...

The upcoming Biotech Act will be part of the measures the Commission will target to turbo-charge investment and efficiency in ...

On December 17, 2024, the Competition Tribunal (the Tribunal) issued reasons for its decision to dismiss an application for leave to bring a ...

The Global Digital Compact (GDC) was officially adopted by United Nations member states on September 22, 2024, during the Summit of the Future, held in New York from September 21 to 25, 2024. The ...

Agnes Asagbra has emphasized the importance of safely utilizing modern biotechnology to promote environmental sustainability.

In the tough market conditions last year, investors and big pharma companies were more likely to place their bets on later, clinical-stage companies. But local biotech leaders see signs of change in ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...

Thanks to a $4.3 million award, CvilleBioHub is building out a laboratory accelerator providing resources to up-and-coming ...

There are ETFs (Exchange-Traded Funds) that focus on non-dividend stocks, although they may not specifically advertise ...